OTCMKTS:RHHVF Roche (RHHVF) Stock Price, News & Analysis $297.89 +9.19 (+3.18%) As of 03:52 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesShort Interest About Roche Stock (OTCMKTS:RHHVF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Roche alerts:Sign Up Key Stats Today's Range$293.75▼$299.5350-Day Range$273.10▼$299.3652-Week Range$233.12▼$340.88Volume999 shsAverage Volume3,042 shsMarket CapitalizationN/AP/E Ratio27.56Dividend Yield2.62%Price TargetN/AConsensus RatingN/A Company OverviewRoche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.Read More… Roche Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks4th Percentile Overall ScoreRHHVF MarketRank™: Roche scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Roche. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Roche is 27.56, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 111.76.Price to Earnings Ratio vs. SectorThe P/E ratio of Roche is 27.56, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 88.83.Read more about Roche's valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares ShortedShort Interest Ratio / Days to CoverRoche has a short interest ratio ("days to cover") of 97, which indicates bearish sentiment.Change versus previous monthShort interest in Roche has recently increased by 8.84%, indicating that investor sentiment is decreasing significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldRoche pays a meaningful dividend of 3.21%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthRoche does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Roche is 72.16%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Roche's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares ShortedShort Interest Ratio / Days to CoverRoche has a short interest ratio ("days to cover") of 97, which indicates bearish sentiment.Change versus previous monthShort interest in Roche has recently increased by 8.84%, indicating that investor sentiment is decreasing significantly. News and Social Media0.6 / 5News SentimentN/A Search Interest2 people have searched for RHHVF on MarketBeat in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Roche insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 29.01% of the stock of Roche is held by institutions.Read more about Roche's insider trading history. Receive RHHVF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Roche and its competitors with MarketBeat's FREE daily newsletter. Email Address RHHVF Stock News HeadlinesGoldman Sachs Remains a Sell on Roche Holding AG (RHHVF)January 14, 2025 | markets.businessinsider.comBernstein Keeps Their Buy Rating on Roche Holding AG (RHHVF)January 7, 2025 | markets.businessinsider.comA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. January 21, 2025 | Porter & Company (Ad)Roche CEO says no job cuts planned, business is healthy: reportDecember 29, 2024 | msn.comAnalysts Conflicted on These Healthcare Names: Verastem (VSTM), Roche Holding AG (OtherRHHVF) and Cabaletta Bio (CABA)December 20, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Checkpoint Therapeutics (CKPT) and Roche Holding AG (OtherRHHVF)December 16, 2024 | markets.businessinsider.comKepler Capital Sticks to Their Buy Rating for Roche Holding AG (RHHVF)December 6, 2024 | markets.businessinsider.comThe Intersection of AI, Medicine, and Stocks: A New Era of Opportunities Issued on behalf of Avant Technologies Inc.December 5, 2024 | tmcnet.comSee More Headlines RHHVF Stock Analysis - Frequently Asked Questions How have RHHVF shares performed this year? Roche's stock was trading at $280.00 at the start of the year. Since then, RHHVF shares have increased by 6.4% and is now trading at $297.8919. View the best growth stocks for 2025 here. How do I buy shares of Roche? Shares of RHHVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today1/21/2025Next Earnings (Estimated)1/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - General Sub-IndustryPersonal Services Current SymbolOTCMKTS:RHHVF CUSIPN/A CIKN/A Webwww.roche.com Phone(161) 688-1111FaxN/AEmployees103,605Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio27.56 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report This page (OTCMKTS:RHHVF) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roche Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Roche With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.